Amendment 12 - Laserfiche WebLink

Home Browse Search

, Task Task! ActivitylDescription Number b) Conduct AFIX follow-up visits with all provider sites receiving an AFIX visit. Follow-up visits can be conducted in-person, by telephone, or by webinar. All AFIX follow-up visits must be completed six (6) months after the feedback visit. Continue following up with provider sites until they fully implement their selected quality improvement activities. 8 a) In coordination with hospitals, health care providers, and health plans (if applicable), conduct activities to prevent perinatal hepatitis B infection in accordance with the Perinatal Hepatitis B Prevention Program Guidelines, including the following: 1) Identification ofHBsAg-positive pregnant women, and pregnant women with unknown HBsAg status 2) Reporting ofHBsAg-positive women and their infants 3) Case management for infants born to HBsAg-positive women to ensure administration of hepatitis B immune globulin (HBIG) and hepatitis B vaccine within twelve (12) hours of birth, the completion of the 3-dose hepatitis B vaccine series, and post-vaccination serologic testing. b) Provide technical assistance to birthing hospitals to encourage administration of the hepatitis B birth dose to all newborns within twelve (12) hours of birth, in accordance with Advisory Committee on Immunization Practices (ACIP) recommendations. c). Report all perinatal hepatitis B investigations, including HBsAg-positive infants, in the Perinatal Hepatitis B Module of the Washington State Immunization Information System. Exhibit A, Statements of Work Revised as of May 15, 2017 AMENDMENT #12 *May Support PHAB Deliverables/Outcomes Payment Information StandardslMeasures Due Date/Time Frame and/or Amount I b) Enter the following data in b) Within five (5) days of *See Restrictions on the Exchange tab of the AFIX visit. All follow-up Funds below Online Tool for follow-up visits must be visits: completed six (6) • Clinic progress on months after the implementing quality feedback visit. improvement strategies. • Follow-up coverage assessment results (from CoCASA reports). a) Enter information for a) By the last day of each Reimbursement for each case identified into month actual costs incurred , the Perinatal Hepatitis B not to exceed total module of the W A funding consideration Immunization amount. Information System Funds available for this b) Annual Perinatal Hepatitis b) December 15th task*: B Outreach Summary (DOH 348 268) January 2017 - I March 2017 FFY16 PPHF 317 Ops- 74110267 April 2017 - December 2017 FFY17 317 Ops- 74110271 *See Restrictions on Funds below Page 8 of 10 Contract Number C 17114-12